Studied in trials
Studied regimens (not recommendations)
Studied in trials — not a recommended dose
- Intra-articular: single injection into knee (case series, no standardized dose reported).
- Intravesicular: reported in pilot study for interstitial cystitis (dose not specified in available sources).
- IV: up to 20 mg in two healthy adults; well tolerated.
- SC: 14 days daily dosing in ongoing Phase 2 trial (NCT07437547), dose not yet published.